Grants 2008
Janssen Pharmaceutica NV, a division of Johnson & Johnson Pharmaceutical
“Drug sensitivity profiling and identification of signatures of response in breast carcinoma”
PI: Mieke Schutte, John Martens and John Foekens
€ 285.000
Netherlands Proteomics Centre (NPC 2009-2013)
"Identification of prognostic protein markers for triple negative breast cancer"
PI: John Foekens
€ 220.000
Pink ribbon
“Protein Markers for the Early Detection of Breast Cancer: Identification with a Combined Tissue and Serum Proteomic Approach”
PI’s: Arzu Umar en John Foekens
€ 50.000
Center for Translational Molecular Medicine
“Neoadjuvant drug treatment for Breast CAncer-REsponse-prediction and response monitoring”
Acronym: BREAST CARE
PI: S. Rodenhuis– Nederlands Kanker Instituut (NKI), Amsterdam.
Participants: NKI, Amsterdam, and Erasmus MC, Rotterdam, PI: John Foekens
EORTC Translational Research Award
PI: Els Berns and Maria van der Burg
€ 20.000
Dutch Scientific Research Society - Translational Gene Therapeutic Research NWO-ZonMW, round 4-2007
Oncolytic adenovirus therapy as a neoadjuvant treatment for localised prostate cancer.
Project leader: Chris Bangma.
Project team members: Chris Bangma, Ellen Schenk, Robert Kraaij, Jan Willem Gratama, Bart Haagmans, Arnold Vulto, Arno van Leenders, Cor Lamers, Reno Debets.
€ 180.000 (for Jan Willem Gratama, Cor Lamers, Reno Debets)
Erasmus MC Grant
"Identification of HuD-specific T-cell epitopes involved in autoimmunity and cancer immunity"
PI: Peter Sillevis Smitt and Jan-Willem Gratama
€ 50.000
Zon MW Agiko-stipendium
"The role of HuD-specific T cells in autoimmunity and cancer immunity"
PI: Peter Sillevis Smitt and Jan-Willem Gratama
€ 64.000